Clinical trials experts emphasize the importance of keeping states informed about ongoing clinical trials to ensure transparency and accountability in the process. The experts point out that involving states in the decision-making and monitoring of clinical trials can help address concerns related to the safety and efficacy of experimental treatments. It is crucial for states to have access to information about the trials being conducted within their jurisdiction to safeguard the interests of participants and the public. By keeping states informed, regulatory bodies can ensure that ethical standards are upheld and that participants are protected from any potential risks. Experts also stress the need for a collaborative approach between states and regulatory authorities to streamline the process of conducting clinical trials in India. This collaboration can help in addressing regulatory hurdles and ensuring timely approvals for research studies. Overall, the involvement of states in clinical trials can lead to greater transparency, accountability, and public trust in the healthcare system.